Byotrol Share Discussion Threads

[1gw] 16/9/2021 10:15

I don't remember coming across the TraffiGlove relationship before, but noticed the logo on the "Key Investment Case" slide. Presumably an old (but still current) and/or relatively minor deal, given its positioning on the slide below Rentokil Initial?

[1gw] 16/9/2021 10:09

SMT - what a choice of username for someone appearing to want to engage in serious debate about the company and its prospects!

We barely have enough interest in the company to have any discussion on a public bb, never mind a guild that provides an extra hurdle to participation. I try not to rise to the bait of stt's posts too often, but am happy to use them on occasion as a starting point for making a point about the business - such as how I think the company has successfully "grasped the opportunity" of the recent extraordinary environment by completing an impressive number of multi-year licence deals.

If you are really dismayed by the quality of posting on the bulletin board, perhaps you would like to contribute posts of an appropriate quality to raise the overall level?

[slapmytodger] 16/9/2021 09:45

I am amazed at the garbage written on this bb, it is pretty clear most are not investors or bothered to listen to the investor meet company presentation or brave enough to ask a question or phone/ email the ceo. The attack by stt is worrying and must be competitor driven yet intelligent contributors such as 1gw seem to want to waste time responding to his clueless postings. Ditto brownson.
Is it not time for a guild where we can have a proper debate. This is a v cheap company but not the easiest to understand. The share register includes some very smart investors who don’t like losing money and is normally a good starting point for discussion.

[the ghost who walks] 15/9/2021 17:31

Absolute nonsense.

[football] 15/9/2021 16:06

Micro did a lot of that money come from a 55p placing Tottally did and then started a share buy back at 15p while paying a divi from that placing



talk about robbimg shateholders to fill the borads pockets

[sikhthetech] 15/9/2021 15:44

And they raised £4.3m(before expenses) in 2017.... to build a marketing team and to build a stronger balance sheet.

Yet when it came to covid, where was all the marketing???


"It was apparent that the team was going to need more finance to invest in sales and marketing and to build a small team in the US to commercialise the newly-received EPA product registration. I also felt that we needed a stronger
balance sheet as it was clear that the team had to make short term decisions to generate immediate cash flow and margin. While this was necessary due to the Company’s financial position, a stronger balance sheet will enable the business to take the longer-term view and provide greater comfort to our customers and suppliers.
So, I was very pleased that post year end we were able to conditionally raise £4.3 million before expenses in new
equity capital from new and existing investors through a placement and subscription. An open offer is also available
to existing shareholders up to a maximum of £1.1 million."

[microscope] 15/9/2021 15:36

Football, changing the agenda really won't help you, but as you brought it up, I was discussing the cash position.Byotrol 2.8 million 2019, to a thin looking 1.6 million now.Totally March 2019, 7.5 million, now a healthy looking 14.8 million.Back to Byotrol, and I sympathize with the concerns you have expressed here. :)

[sikhthetech] 15/9/2021 14:56

Micro
"It really has become an IP play and if they are to fund significant expansion, I suspect they'll need to raise funds to achieve meaningful growth"

They've had declining cash for years, which was my concern last year.



sikhthetech - 15 May 2020 - 11:02:32 - 5955 of 8742 BYOTROL-CAN DELIVER AMAZING
If they had to increase manufacturing capacity then have they got the cash to do so?

With £1.7m cash, as of 31st March, I wonder if they will have a placing soon to help pay for increasing capacity?

Cash balances have been declining for years..
Cash:
fy2018 £3.85m
fy2019 £2.8m
H12020 £2.01m
fy2020 £1.7m (expectation was £2.6m)


sikhthetech - 09 Feb 2020 - 16:41:45 - 4253 of 8742 BYOTROL-CAN DELIVER AMAZING
<...>
Obviously they will gain some additional cash from the spike resulting from the Coronavirus but how far will that go... and will it be enough to prevent another placing?

Company's

Weak cash position:
"At the year-end we had cash resources of £2.8m (2018: £3.85m) which is sufficient to finance our ongoing operations and the remaining earnout payments to Medimark's vendors but not to fund additional resources, capabilities and nationwide marketing expenditure in the US."


<...>

[football] 15/9/2021 14:49

Byotrol £22k a week profit on £11.1m

Tottally £1k a week profit on £113m

[microscope] 15/9/2021 14:48

On a less theoretical (but rather more practical) level, while I mentioned the relative strength of the balance sheet compared to previous years, nevertheless I've been taking a look at the cash position, which looks less than impressive.

3.85 million in 2018, 2.8 million the following year (which was a key reason given for not expanding in the US).

1.4 million cash in 2020, before a minor improvement to 1.6 million in 2021 (and guaranteed minimum IP of 1.6 million for next year, v 1.3 million).

Expansion in the US would have meant funding requirements, at the company's own admission, and while that is more expensive than elsewhere, nevertheless if 2.8 million was inadequate, how much 1.6 million will allow closer to home must be highly debatable.

It really has become an IP play and if they are to fund significant expansion, (mainly by growing profit via those IP deals, and/or landing new ones), I suspect they'll need to raise funds to achieve meaningful growth, at a time when money is tight in the wider economy, and their own supply chain less than smooth.

Also the chart is imho at a vital support level which needs to hold.

[sikhthetech] 15/9/2021 14:43

1gw
"I think we may find that by focusing on completing multi-year licensing agreements during the pandemic they have indeed grasped the opportunity"

Really...

It's jam tomorrow.


What happened to all the opportunities they grasped after SWINE flu A DECADE AGO???


BoD have been saying similar for years.

The comments below were made A DECADE AGO, when Swine flu was supposedly be the catalyst for future growth...so nothing new.

The fact is these were pumped based on Boots being one of the retailers who sells Byot based products.
And Boots is a national retailer so would get PIs interested.


"The significant increase in sales is in part due to the concern regarding swine flu; however it can also be attributed to a greater appreciation of the qualities, efficacy and broad applications of Byotrol. "

"We remain confident of the prospects for Byotrol "

Distributors & Parners
" Healthcare through our relationship with Synergy Health plc in Europe and through distributors in the US
* Food and beverage, both through distributors and direct sales
* Consumer products through our joint venture, Byotrol Consumer Products Ltd. "

[1gw] 15/9/2021 14:23

I think we may find that by focusing on completing multi-year licensing agreements during the pandemic they have indeed grasped the opportunity. Just as a reminder:

FY20
Tristel - 3 products - announced March 2020
Advanced Hygienics (extension) - not announced until prelims in Sept 2020

FY21
Integrated Resources - Americas (byotrol24) - announced May 2020
SCJ Professional - announced May 2020
Turtle Wax Europe - announced April 2021
Byoworks - sub-Saharan Africa - announced April 2021
Soltech - Middle East - announced April 2021

So 6 multi-year license agreements (and possibly 7, depending on when the Advanced Hygienics deal was done) completed after the pandemic began. I think it would be reasonable to assume that by doing this byotrol will have managed to lock in more attractive terms than had they done them before the pandemic. The rewards from these agreements will not be evident until the end of the terms, as only then will it become clear how much royalty each has generated and how valuable a renewal or re-tender then is.

In addition, Solvay appear to have grasped the opportunity by accelerating their work on Actizone.

All these things play out over many years. I would suggest that the ultimate rewards from this concentration of effort on securing new multi-year licence deals may well be far in excess than could have been achieved by trying to capture more of the short-term very high demand during the early stages of the pandemic.

[sikhthetech] 15/9/2021 13:38

1gw
"In a few years"

Yes, as I said jam tomorrow... In a few years other companies will again adapt to what is in demand...


They were presented with the perfect opportunity and failed to grasp it... Maybe they will 'in a few years'...

Oh wait, they had a similar opportunity a few years ago (decade ago) with Swine flu... what happened???

[1gw] 15/9/2021 12:13

And this quote also quite revealing, both on the technical edge of Actizone and on the desire of some of Solvay's big customers for an exclusive deal on Actizone. Of course, technical superiority doesn't always win out over good marketing, but it's a good start.

"Residual disinfectants are designed to leave a residue on the very surface they’re supposed to clean: it’s a contradiction in terms, and a seemingly impossible task that has eluded experts for decades. So it was a real scientific challenge: we had to push the boundaries to get maximum efficacy with an ultrathin film and a minimum amount of chemicals – that’s where the innovation lies. Also, the residue left by Actizone™ transforms what a surface is, from a passive recipient of infectious pathogens to a delivery vehicle that actively eliminates them – hence the name of the product. Our customers, with their hundreds of years of experience and many researchers, were so impressed they all wanted us to work with them exclusively. But we wanted to have the broadest impact possible."

[1gw] 15/9/2021 12:01

From the same article, this quote encapsulates the potential quite nicely, I think:

"In a few years, everyone will expect that when you’ve just cleaned a surface, it will stay disinfected for a day. That shift in thinking is what we’re aiming for, and it’s inspiring to think that our team is at the center of that change."

[1gw] 15/9/2021 11:57

Good recent article (9th Sept) from Solvay on Actizone, which among other things confirms they have started the US registration process:

"How about now, are you still working on Actizone™?
We’re always working on it! We’ve launched in Europe and South Asia, with lots of regulatory oversight and approval to get through, and have entered the registration process for the US."

Also plays up their technical capability vs byotrol:

"We were approached by a company that wanted to use a Solvay polymer system to develop a long-lasting disinfection product, but was unable to reach satisfactory efficacy. We instantly knew what to do and took it from there, partnering with them to pursue the work with our critical insight for global product prototypes."

[football] 14/9/2021 20:51

Maybe Byotrol should up date there share register to clear this upHTtps://twunroll.com/article/1338228327606259712#

[football] 14/9/2021 20:14

We will never get 3 days a in roll

[the ghost who walks] 14/9/2021 17:52

Another up day!

[loafofbread] 13/9/2021 21:45

Blueeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeee.

[the ghost who walks] 13/9/2021 19:10

An up day!

[football] 13/9/2021 12:03

Good old STD trying to scare everyone with AGM's should be within 6-months of end year year and then putting up a link to a government website to back up his claim and sound importantOnly problem like most of he's links they backfire and it still says there's a 3 month Grace period due to covid

[the ghost who walks] 13/9/2021 11:56

Got it, thanks